NO882242L - Stabilisering av biologiske og farmasoeytiske produkter under varmeinaktivering av virale og bakterielle forurensninger. - Google Patents

Stabilisering av biologiske og farmasoeytiske produkter under varmeinaktivering av virale og bakterielle forurensninger.

Info

Publication number
NO882242L
NO882242L NO88882242A NO882242A NO882242L NO 882242 L NO882242 L NO 882242L NO 88882242 A NO88882242 A NO 88882242A NO 882242 A NO882242 A NO 882242A NO 882242 L NO882242 L NO 882242L
Authority
NO
Norway
Prior art keywords
biological
viral
stabilization
under heat
pharmaceutical products
Prior art date
Application number
NO88882242A
Other languages
English (en)
Other versions
NO176234C (no
NO882242D0 (no
NO176234B (no
Inventor
Fred Feldman
Mark S Klekamp
Michael E Hrinda
Arthur B Shaw
Sudhish Chandra
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of NO882242D0 publication Critical patent/NO882242D0/no
Publication of NO882242L publication Critical patent/NO882242L/no
Publication of NO176234B publication Critical patent/NO176234B/no
Publication of NO176234C publication Critical patent/NO176234C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO882242A 1987-05-22 1988-05-20 Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale NO176234C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5292687A 1987-05-22 1987-05-22

Publications (4)

Publication Number Publication Date
NO882242D0 NO882242D0 (no) 1988-05-20
NO882242L true NO882242L (no) 1988-11-23
NO176234B NO176234B (no) 1994-11-21
NO176234C NO176234C (no) 1995-03-01

Family

ID=21980809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882242A NO176234C (no) 1987-05-22 1988-05-20 Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale

Country Status (11)

Country Link
EP (1) EP0292003B1 (no)
JP (2) JP2605102B2 (no)
AT (1) ATE103185T1 (no)
AU (1) AU606159B2 (no)
CA (1) CA1337688C (no)
DE (1) DE3888571T2 (no)
ES (1) ES2061554T3 (no)
FI (1) FI95778C (no)
IL (1) IL86417A (no)
NO (1) NO176234C (no)
NZ (1) NZ224740A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
EP0440509A3 (en) * 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
DK1820516T3 (da) 1999-02-22 2013-10-28 Univ Connecticut Nye albuminfrie faktor VIII-præparater
MX2007015039A (es) * 2005-06-06 2008-01-24 Novo Nordisk As Composiciones de il-21 estabilizadas.
DE102006008613A1 (de) * 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第7因子含有水溶液の加熱処理方法
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第8因子の加熱処理法
CA1213827A (en) * 1983-04-29 1986-11-12 Ricardo H. Landaburu Process for pasteurizing fibronectin
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPS61189228A (ja) * 1985-02-19 1986-08-22 Nippon Sekijiyuujishiya 血液凝固第8因子製剤の製法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
JPS6289628A (ja) * 1985-09-11 1987-04-24 Green Cross Corp:The 人フイブリノゲン製剤の加熱処理法
JPS6281327A (ja) * 1985-10-04 1987-04-14 Green Cross Corp:The 人トロンビン製剤の加熱処理方法

Also Published As

Publication number Publication date
JPH09118634A (ja) 1997-05-06
EP0292003A2 (en) 1988-11-23
AU1664288A (en) 1988-11-24
DE3888571T2 (de) 1994-08-11
IL86417A (en) 1992-09-06
IL86417A0 (en) 1988-11-15
JP2605102B2 (ja) 1997-04-30
NO176234C (no) 1995-03-01
JP2879427B2 (ja) 1999-04-05
EP0292003B1 (en) 1994-03-23
FI95778B (fi) 1995-12-15
FI882387L (fi) 1988-11-23
FI882387A0 (fi) 1988-05-20
NZ224740A (en) 1990-01-29
ES2061554T3 (es) 1994-12-16
EP0292003A3 (en) 1990-06-13
JPS649937A (en) 1989-01-13
CA1337688C (en) 1995-12-05
FI95778C (fi) 1996-03-25
DE3888571D1 (de) 1994-04-28
NO882242D0 (no) 1988-05-20
AU606159B2 (en) 1991-01-31
NO176234B (no) 1994-11-21
ATE103185T1 (de) 1994-04-15

Similar Documents

Publication Publication Date Title
NO882242D0 (no) Stabilisering av biologiske og farmasoeytiske produkter under varmeinaktivering av virale- og bakterielle forurensninger.
DE69432351D1 (de) Verfahren zum sterilisieren von produkten
EP0691270A3 (en) Device and method for sterilizing and packaging blister packs in boxes
ZA887195B (en) Novel process
DE68903558D1 (de) Verfahren zur inaktivierung von viren.
ATE72127T1 (de) Sterilisationsverfahren.
SE8803071L (sv) Bakteriebehandling foer att bevara hoekvalitet genom att tillaegga genius bacillus mikroorganismer
EP0633786A4 (en) METHOD FOR INACTIVATING VIRAL AND BACTERIAL BLOOD IMPURITIES.
PT86393A (en) Process for the preparation of therapeutical and prophylatic agents containig pp4 of tissue protein and for the purification of these proteins
FI914026A0 (fi) Foerfarande foer framstaellning av genomsynlig reglerad mjoelkvassleprotein och reglerad mjoelkvassleproteinprodukt.
EP0124044A3 (en) Process for pasteurizing fibronectin
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
GR3017807T3 (en) Method for inactivating biological activity of DNA.
DE3485610D1 (de) Verfahren zur erhaltung und vermehrung von defekten, nicht-infektioesen virusgenomen.
EP0249167A3 (en) Process for preparing a pasteurized immunoglobulin preparation
CS592184A2 (en) Method of biologically active substance production with immunostimulating effect
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
SE8700136L (sv) Forfarande for behandling av amfotera aminosyror
Digeronimo Sterilization of packaging material.
FI883226L (fi) Kontrollindikator foer gassterilisering.

Legal Events

Date Code Title Description
MK1K Patent expired